Drupal.behaviors.print = function(context) {window.print();window.close();}>
Aria Plans Clinical Trial of T21 Dx in 25K Women; Says Test Does Not Infringe Sequenom IP
January 18, 2012
Aria Plans Clinical Trial of T21 Dx in 25K Women; Says Test Does Not Infringe Sequenom IP
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Lo Team Finds Targeted, SNP-Based Approach for T21 Detection 'Less Robust' than Shotgun Sequencing
May 30, 2012 / Clinical Sequencing News
Sequenom Files Preliminary Injunction Motion Against Aria
February 29, 2012 / Clinical Sequencing News
Verinata Health Sets March Launch Date for Trisomy Test; Presents Results from Validation Study
February 15, 2012 / Clinical Sequencing News
Sequenom Validates MaterniT21 for Trisomy 18 and 13 Detection
February 8, 2012 / Clinical Sequencing News
Sequenom Sues Aria and Natera for Patent Infringement
January 25, 2012 / Clinical Sequencing News